TY - JOUR
T1 - Multidisciplinary management of advanced prostate cancer
T2 - Changing perspectives on referring patients and enhancing collaboration between oncologists and urologists in clinical trials
AU - Carducci, Michael A.
AU - Carroll, Peter R.
AU - Smith, Matthew R.
AU - DiPaola, Robert S.
AU - Nelson, Joel B.
PY - 2005/5
Y1 - 2005/5
N2 - Prostate cancer traditionally was managed by monotherapy, and treatment was almost exclusively provided by the urologic surgeon. As ongoing clinical trials in advanced disease identify novel agents or combination therapies with good tolerability and potential survival benefits, multidisciplinary management may offer optimal care for men with high-risk prostate cancer, as it does for women with breast cancer. Patients with high-risk recurrent or metastatic disease should be informed of clinical trials for which they may be eligible.
AB - Prostate cancer traditionally was managed by monotherapy, and treatment was almost exclusively provided by the urologic surgeon. As ongoing clinical trials in advanced disease identify novel agents or combination therapies with good tolerability and potential survival benefits, multidisciplinary management may offer optimal care for men with high-risk prostate cancer, as it does for women with breast cancer. Patients with high-risk recurrent or metastatic disease should be informed of clinical trials for which they may be eligible.
UR - http://www.scopus.com/inward/record.url?scp=18244410137&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=18244410137&partnerID=8YFLogxK
U2 - 10.1016/j.urology.2005.03.044
DO - 10.1016/j.urology.2005.03.044
M3 - Article
C2 - 15885275
AN - SCOPUS:18244410137
SN - 0090-4295
VL - 65
SP - 18
EP - 22
JO - Urology
JF - Urology
IS - 5 SUPPL.
ER -
